Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications
Alice Indini, Francesco Grossi, Mario Mandalà, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 607-607
Open Access | Times Cited: 15

Showing 15 citing articles:

Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter
Jessica Thornton, Gagan Chhabra, Chandra K. Singh, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 37
Targeting inflamed and non-inflamed melanomas: biological background and clinical challenges
Alice Indini, Daniela Massi, Matteo Pirro, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 477-490
Open Access | Times Cited: 20
Connecting Metabolic Rewiring With Phenotype Switching in Melanoma
Paola Falletta, Colin R. Goding, Yurena Vivas
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 20
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets
Alice Indini, Irene Fiorilla, Luca Ponzone, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9985-9985
Open Access | Times Cited: 18
A new era in melanoma immunotherapy: focus on DCs metabolic reprogramming
Mina Afrashteh Nour, Mansour Rajabivahid, Marjan Sadat Seyed Mehdi, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: Predict before protect
Xinyue Zhang, Zongguang Tai, Fengze Miao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Salviolone from Salvia miltiorrhiza Roots Impairs Cell Cycle Progression, Colony Formation, and Metalloproteinase-2 Activity in A375 Melanoma Cells: Involvement of P21(Cip1/Waf1) Expression and STAT3 Phosphorylation
Valentina Zanrè, Rachele Campagnari, Antonietta Cerulli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1121-1121
Open Access | Times Cited: 12
The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma
Yue lv, Chunhui Yuan, Lu-yao Han, et al.
Disease Markers (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 10
Dermoscopic Criteria, Histopathological Correlates and Genetic Findings of Thin Melanoma on Non-Volar Skin
Cesare Massone, Rainer Hofman‐Wellenhof, Stefano Chiodi, et al.
Genes (2021) Vol. 12, Iss. 8, pp. 1288-1288
Open Access | Times Cited: 11
Identification of Dihydrolipoamide Dehydrogenase as Potential Target of Vemurafenib-Resistant Melanoma Cells
Claudio Tabolacci, Deborah Giordano, Stefania Rossi, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7800-7800
Open Access | Times Cited: 8
Clinical and molecular overview of immunotherapeutic approaches for malignant skin melanoma: Past, present and future
Raphaelly Venzel, Maria Clara Paulino Campos, Larissa Pessoa de Oliveira, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 186, pp. 103988-103988
Closed Access | Times Cited: 4
ROS Pleiotropy in Melanoma and Local Therapy with Physical Modalities
Sanjeev Kumar Sagwal, Sander Bekeschus
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 8
Pathology of Immunotherapy-induced Responses in Cutaneous Melanoma: Current Evidences and Future Perspectives
Alice Indini, M. Lombardo, Angelo Sidoni, et al.
Advances in Anatomic Pathology (2022) Vol. 30, Iss. 3, pp. 218-229
Closed Access | Times Cited: 3
The role of immune metabolism in skin cancers: implications for pathogenesis and therapy
Xuanyu Lu, Yurui Zhu, Tianyu Qin, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 7, pp. 3898-3903
Open Access
Reconnoitring signaling pathways and exploiting innovative approaches tailoring multifaceted therapies for skin cancer
Deepanjan Datta, Safiya Sulthana, Jordan Strauss, et al.
International Journal of Pharmaceutics (2024) Vol. 665, pp. 124719-124719
Open Access
Page 1

Scroll to top